Literature DB >> 6264121

Presence of the cap-binding protein in initiation factor preparations from poliovirus-infected HeLa cells.

J Hansen, E Ehrenfeld.   

Abstract

Crude preparations of initiation factors from mock-infected and poliovirus-infected HeLa cells were analyzed for the presence of proteins which could be cross-linked to the 5' cap group of mRNA. A protein having an apparent molecular weight of 26,000, similar to the cap-binding protein in rabbit reticulocytes described by Sonenberg and Shatkin (Proc. Natl. Acad. Sci. U.S.A. 75:4843-4847, 1978), was found in the ribosomal salt wash from both uninfected and infected cells. Cross-linking of this polypeptide was inhibited by the cap analog m7GMP. In addition, cross-linking of a protein having an approximate molecular weight of 60,000 was similarly inhibited by cap analog. The smaller cap-binding protein fractionated in a 0 to 40% ammonium sulfate precipitate of ribosomal salt wash; the larger protein was found in the 40 to 70% ammonium sulfate fraction. Although the cap-binding proteins were present in both mock-infected and poliovirus-infected ribosomal salt wash, only preparations from uninfected HeLa cells were able to restore translation of capped vesicular stomatitis virus mRNA by extracts prepared from poliovirus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264121      PMCID: PMC171175     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes.

Authors:  S Muthukrishnan; M Morgan; A K Banerjee; A J Shatkin
Journal:  Biochemistry       Date:  1976-12-28       Impact factor: 3.162

2.  Structure and function of free 40 S ribosome subunits: Characterization of initiation factors.

Authors:  I C Sundkvist; T Staehelin
Journal:  J Mol Biol       Date:  1975-12-15       Impact factor: 5.469

3.  Untranslated vesicular stomatitis virus messenger RNA after poliovirus infection.

Authors:  E Ehrenfeld; H Lund
Journal:  Virology       Date:  1977-07-15       Impact factor: 3.616

4.  Control of protein synthesis in extracts from poliovirus-infected cells. I. mRNA discrimination by crude initiation factors.

Authors:  T Helentjaris; E Ehrenfeld
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

5.  Initiation of mammalian protein synthesis: the importance of ribosome and initiation factor quality for the efficiency of in vitro systems.

Authors:  M H Schreier; T Staehelin
Journal:  J Mol Biol       Date:  1973-02-19       Impact factor: 5.469

6.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

7.  Shutoff of HeLa cell protein synthesis by encephalomyocarditis virus and poliovirus: a comparative study.

Authors:  G Jen; B M Detjen; R E Thach
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

8.  Reovirus mRNA can be covalently crosslinked via the 5' cap to proteins in initiation complexes.

Authors:  N Sonenberg; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

9.  Poliovirus-induced inhibition of polypeptide initiation in vitro on native polyribosomes.

Authors:  Y Kaufmann; E Goldstein; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

10.  Regulation of protein synthesis in HeLa cells. 3. Inhibition during poliovirus infection.

Authors:  R Leibowitz; S Penman
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

View more
  14 in total

1.  Localization of cap-binding protein in subcellular fractions of HeLa cells.

Authors:  J L Hansen; D O Etchison; J W Hershey; E Ehrenfeld
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

2.  Capped mRNAs with reduced secondary structure can function in extracts from poliovirus-infected cells.

Authors:  N Sonenberg; D Guertin; K A Lee
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

3.  Monoclonal antibody-aided characterization of cellular p220 in uninfected and poliovirus-infected HeLa cells: subcellular distribution and identification of conformers.

Authors:  D Etchison; J R Etchison
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

4.  Isolation and structural characterization of cap-binding proteins from poliovirus-infected HeLa cells.

Authors:  K A Lee; I Edery; N Sonenberg
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

5.  Amino acid sequence of the mRNA cap-binding protein from human tissues.

Authors:  W Rychlik; L L Domier; P R Gardner; G M Hellmann; R E Rhoads
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Separation of protein synthesis initiation factor eIF4A from a p220-associated cap binding complex activity.

Authors:  D Etchison; S Milburn
Journal:  Mol Cell Biochem       Date:  1987-07       Impact factor: 3.396

7.  Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells.

Authors:  D Etchison; J Hansen; E Ehrenfeld; I Edery; N Sonenberg; S Milburn; J W Hershey
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

8.  Photochemical cross-linking of cap binding proteins to eucaryotic mRNAs: effect of mRNA 5' secondary structure.

Authors:  J Pelletier; N Sonenberg
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

9.  Association of cap-binding protein with eucaryotic initiation factor 3 in initiation factor preparations from uninfected and poliovirus-infected HeLa cells.

Authors:  J Hansen; D Etchison; J W Hershey; E Ehrenfeld
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

10.  Inhibition of host translation in encephalomyocarditis virus-infected L cells: a novel mechanism.

Authors:  G Jen; R E Thach
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.